We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

104 hedge funds and large institutions have $713M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 50 increasing their positions, 32 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 32

17% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 12

2% more funds holding

Funds holding: 102 → 104 (+2)

1% more capital invested

Capital invested by funds: $704M → $713M (+$8.99M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

53% less call options, than puts

Call options by funds: $1.16M | Put options by funds: $2.47M

Holders
104
Holders Change
+2
Holders Change %
+1.96%
% of All Funds
2.99%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
50
Reduced
32
Closed
12
Calls
$1.16M
Puts
$2.47M
Net Calls
-$1.31M
Net Calls Change
-$1.38M

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$12.8M
2
PCM
Pentwater Capital Management
Florida
+$7.7M
3
BFA
BlackRock Fund Advisors
California
+$5.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.15M
5
RG
Redmile Group
California
+$4.09M

Top Sellers

Rank Fund Capital Flow
1
WRF
Waddell & Reed Financial
Kansas
-$6.98M
2
Renaissance Technologies
Renaissance Technologies
New York
-$4.63M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.29M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$3.26M
5
CCM
Cadian Capital Management
New York
-$2.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
Lord, Abbett & Co
26
Lord, Abbett & Co
New Jersey
$5.31M +$1.87M +53,597 +63%
JP Morgan Chase
27
JP Morgan Chase
New York
$4.99M +$371K +10,631 +9%
SAM
28
Senzar Asset Management
New York
$4.79M +$1.24M +35,400 +40%
Allianz Asset Management
29
Allianz Asset Management
Germany
$4.09M -$385K -11,015 -9%
TAM
30
Tocqueville Asset Management
New York
$3.59M +$1.29M +36,920 +65%
AC
31
Ascend Capital
California
$3.35M +$42.4K +1,216 +1%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$3.29M +$605K +17,319 +25%
KCM
33
Kornitzer Capital Management
Kansas
$3.26M +$2.97M +85,055 New
BNP Paribas Asset Management
34
BNP Paribas Asset Management
France
$3.15M +$133K +3,802 +5%
EAM
35
Eagle Asset Management
Florida
$2.7M -$1.08M -30,827 -30%
TCIM
36
TIAA CREF Investment Management
New York
$2.52M +$402K +11,506 +21%
GC
37
Guggenheim Capital
Illinois
$2.26M -$715K -20,485 -26%
HM
38
HealthCor Management
New York
$2.06M +$1.88M +53,800 New
BIM
39
BlackRock Investment Management
Delaware
$1.93M +$609K +17,455 +53%
BCM
40
BBT Capital Management
Texas
$1.92M – – –
TCM
41
Tekla Capital Management
Massachusetts
$1.88M +$1.71M +49,000 New
AC
42
Amici Capital
New York
$1.76M +$1.43M +41,000 +820%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.73M -$105K -3,013 -6%
MAA
44
Managed Account Advisors
New Jersey
$1.67M +$621K +17,790 +69%
RJA
45
Raymond James & Associates
Florida
$1.48M +$501K +14,361 +59%
Charles Schwab
46
Charles Schwab
California
$1.46M +$292K +8,370 +28%
Ameriprise
47
Ameriprise
Minnesota
$1.4M +$126K +3,617 +11%
PIM
48
Partner Investment Management
California
$1.39M -$113K -3,226 -8%
AP
49
AlpInvest Partners
Netherlands
$1.28M +$386K +11,047 +50%
AQR Capital Management
50
AQR Capital Management
Connecticut
$1.2M +$325K +9,300 +42%
1
2
3 4 5

KYTH Hedge Fund Activity: Q2 2014 in Review

104 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q2 2014, worth a combined $713M — up 1.3% from $704M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new KYTH positions and 12 closed out — a net gain of 2 holders — while 50 added to existing stakes and 32 trimmed.

The largest buyer was Jennison Associates, adding an estimated $12.8M. The largest seller was Waddell & Reed Financial, cutting an estimated $6.98M.

  • 104 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q2 2014, up from 102 in Q1 2014.
  • Funds reported $713M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q2 2014, up 1.3% quarter-over-quarter.
  • 14 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q2 2014 and 12 closed out, a net change of +2 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q2 2014 was Jennison Associates, an estimated $12.8M added.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q2 2014 was Waddell & Reed Financial, an estimated $6.98M sold.

Based on aggregated 13F filings for Q2 2014.